BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

4D Molecular Therapeutics Inc. (NASDAQ:FDMT)

1 post

Biotech News4D Molecular (FDMT): The Gene Therapy Stock With 100%+ Upside Potential

  • BioTech Health X
  • August 1, 2025
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) is a clinical-stage biotechnology company dedicated to developing next-generation gene therapies using its…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • LifeVantage (LFVN) Faces Big Questions Despite Its Global Growth
  • Can Forward Industries (FORD) Turn Its 60-Year Legacy Into Market Gold?
  • Investors Are Betting Big on Palvella Therapeutics (PVLA)
  • Zimmer Biomet (ZBH)’s 3% Gain Could Be a Trap for Investors
  • Johnson & Johnson (JNJ) Is Trading Near Highs—But Analysts Warn of a Reality Check
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • August 24, 2025
    LifeVantage (LFVN) Faces Big Questions Despite Its Global Growth
    • August 24, 2025
    Can Forward Industries (FORD) Turn Its 60-Year Legacy Into Market Gold?
    • August 24, 2025
    Investors Are Betting Big on Palvella Therapeutics (PVLA)
    • August 24, 2025
    Zimmer Biomet (ZBH)’s 3% Gain Could Be a Trap for Investors
    • August 20, 2025
    Johnson & Johnson (JNJ) Is Trading Near Highs—But Analysts Warn of a Reality Check
Recent Posts
  • Analysts Call Boston Scientific (BSX) a “Forever Company” for Investors
    • August 20, 2025
  • Cidara (CDTX)’s $400 Million Raise: Lifeline or Investor Trap?
    • August 20, 2025
  • Jazz Pharmaceuticals (JAZZ)’s Latest Deal Could Make—or Break—Its Entire Future
    • August 20, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (327)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top